Knee pain from osteoarthritis (OA) is one of the most common mobility threats in adults over 60. The traditional “end of the road” solution has been total knee replacement (TKR), but many people aren’t ready for surgery—or aren’t good surgical candidates yet. Genicular artery embolization (GAE) has emerged as a minimally invasive option aimed at reducing knee inflammation and pain by targeting abnormal blood flow in the arthritic knee. It’s not a “new knee,” and it doesn’t reverse arthritis, but it may reduce pain and improve function, potentially delaying (or reducing the need for) joint replacement in select patients. RSNA+1

1) What is GAE?

GAE is a catheter-based procedure performed by an interventional radiologist. Using live X-ray imaging, the physician threads a tiny catheter through an artery (often from the groin or wrist area) to the small arteries that supply the knee—called the genicular arteries. Then they inject tiny particles (embolic material) to reduce blood flow to areas of abnormal “hyper vascular” synovial tissue (inflamed joint lining). The goal is to reduce inflammation signals and pain. Brigham and Women’s Hospital+1

Think of it as “turning down the faucet” that feeds chronic inflammation—without cutting into the knee joint or replacing it.

2) Why it may help osteoarthritis pain

In knee OA, inflammation in the synovium can be associated with abnormal new blood vessel growth and increased inflammatory activity. GAE targets those abnormal vessels to reduce inflammatory drive. Arthritis organizations note that while studies have not shown that GAE improves joint structure, there is evidence it can reduce inflammation and relieve symptoms in some patients. Arthritis Foundation

3) What the procedure is like (practical expectations)

GAE typically takes about 1–2 hours, usually with local anesthesia and light sedation, followed by a recovery-room monitoring period. Many centers discharge patients the same day; soreness can last several days. Brigham and Women’s Hospital
Many patients return to normal daily activity within days (with provider-specific restrictions). Brigham and Women’s Hospital+1

4) Who it’s best for (and why this matters after 60)

GAE is generally discussed for people with mild-to-moderate knee OA, persistent pain despite conservative care (exercise/PT, weight management, meds, injections), and those trying to delay knee replacement—or who have medical conditions making surgery riskier. RSNA+1
For adults over 60, that “middle zone” is common: pain and limitation are real, but a full replacement may feel too big (or too soon).

5) Success rate: what the evidence shows

It helps to separate technical success from clinical success:

• Technical success (the arteries were successfully treated) is very high: a 2023 systematic review/meta-analysis reported ~99.7% technical success across included studies. PMC+1
• Symptom improvement: The same review found meaningful average improvements in pain and function scores over about 12 months in studied patients, though the evidence base is still developing (study sizes and designs vary). PMC+1
• Longer follow-up: A 2024 JVIR report found that among those with clinical success at 12 months, about 72% reported sustained success at 24 months (subset analysis). Jvir
• A 2025 prospective single-arm trial reported a clinical success rate of 62% (definition varies by study) with improved pain scores through 12 months. Jvir

Bottom line: Many—but not all—patients improve, and durability can extend into year 2 for a portion of responders, but long-term data (5–10 years) is still limited compared with knee replacement.

6) Pros and cons of GAE

Pros

• Minimally invasive, typically outpatient, small puncture site Brigham and Women’s Hospital
• Faster recovery than surgery (often days vs weeks/months) Georgia Knee Institute+1
• May reduce pain and improve function in selected OA patients PMC+1
• May help people not ready/fit for replacement RSNA+1

Cons

• Does not restore cartilage or correct severe deformity/“bone-on-bone” mechanics (so severe OA may respond less durably) PubMed
• Evidence is growing, but still less definitive than TKR long-term outcomes PMC+1
• Some insurers consider it investigational for OA; coverage can be inconsistent Molina Clinical Policy+1
• Some patients need repeat procedures or still proceed to knee replacement later ScienceDirect

7) Worst-case scenario (and realistic safety picture)

In the meta-analysis, reported adverse events were usually minor; the most common was transient skin discoloration. Rarely, skin ulceration occurred. PMC+1
The major “worst case” clinicians watch for is non-target embolization (particles reaching skin or other tissues), which can cause skin injury (ulceration/necrosis). Technical reviews also discuss rare possibilities like bone or nerve complications, access-site bleeding, contrast reaction, or vessel injury—typical catheter-based risks. ScienceDirect+1

8) When was it discovered?

GAE was first used and documented for recurrent knee bleeding (hemarthrosis), often after knee surgery/arthroplasty, before being adapted to osteoarthritis pain. PubMed+1
Its use for mild-to-moderate knee OA was first reported by Okuno and colleagues in 2015 (early pilot work), and the field has expanded since then. MDPI+1

GAE vs Total Knee Replacement (TKR)

Why people get knee replacements

TKR is generally considered when OA pain and disability remain severe despite conservative therapy, especially when there is advanced structural joint damage, significant functional limitation, or deformity. AAHKS+1

Recovery period comparison

GAE recovery

• Often same-day discharge; soreness may last 3–5 days; many resume daily activities within days. Brigham and Women’s Hospital+1

TKR recovery

• Rehab is structured and longer: early mobility begins immediately, but meaningful functional gains typically unfold over weeks to months, with PT commonly emphasized in the first 6+ weeks and strengthening continuing beyond that. Massachusetts General Hospital+1

How long results last

GAE durability

• Current evidence supports benefit for many patients through 12 months, with a portion sustaining improvement into 24 months, but long-term durability beyond that is still being defined. Jvir+1

TKR durability

• A large systematic review in The Lancet estimated about ~82% of total knee replacements last 25 years (registry-based pooled estimate). The Lancet
  In other words, TKR has the strongest track record for long-lasting structural change.

Specialists involved

• GAE: primarily Interventional Radiology (sometimes in collaboration with orthopedics, sports medicine, or pain specialists). Brigham and Women’s Hospital+1
• TKR: Orthopedic surgeon (joint replacement specialist) plus anesthesiology, inpatient/outpatient physical therapy, and post-op care teams. Massachusetts General Hospital+1

Cost comparison (typical ranges)

Costs vary widely by region, facility, and insurance design, but published discussions put:

• GAE around ~$5,000 outpatient and ~$11,000 inpatient in one cost analysis summary. American Academy of Orthopaedic Surgeons
• Primary TKR: one 2024 cost analysis reported mean total cost around $23,907 (with wide variation). jorthobusiness.org

Medicare coverage (practical guidance)

Total Knee Replacement
Medicare generally covers knee replacement when medically necessary. Coverage depends on setting:

• Part A typically applies to inpatient hospital care.
• Part B applies to outpatient surgery and many related services (PT, DME), with coinsurance rules. Wellcare+1

GAE
Medicare coverage for GAE is more variable in practice because it is newer for OA and may be handled under broader embolization billing/coding pathways. Reimbursement may vary by payer/MAC and often requires documentation of medical necessity and sometimes prior authorization processes. Streamline MD+1
Some insurers explicitly label GAE for OA as investigational due to insufficient long-term evidence, which can influence whether a plan pays. Molina Clinical Policy

Practical tip for patients 60+: before scheduling GAE, ask the treating center to provide (1) the billing codes they plan to use and (2) a written coverage estimate/pre-auth outcome.

Alternatives: injections and other non-surgical options

Cortisone (steroid) injections

Steroid injections are commonly used for short-term symptom relief; costs can be relatively low (one analysis cited ~$70 direct cost). American Academy of Orthopaedic Surgeons
Tradeoffs: relief is usually temporary, and repeated steroid injections may have downsides (your clinician will tailor frequency).

Hyaluronic acid (“gel”) injections

Medicare contractors have LCDs covering hyaluronic acid injections in certain scenarios. One LCD outlines coverage details, and an HHS administrative decision discussed that repeat series are reasonable and necessary only when at least 6 months have elapsed since the prior series (policy context varies by contractor). Centers for Medicare & Medicaid Services+1

Home and “natural” supports (safe, commonly recommended)

These won’t “cure” OA, but they often reduce pain and improve function—especially important for adults over 60 trying to stay mobile:

• Strengthening + low-impact activity (quad/hip strength, walking, cycling, water exercise)
• Weight management (even small reductions can lower knee load)
• Heat/ice, bracing, cane/walking poles as needed
• Topical options (e.g., topical NSAIDs if appropriate)
• Supplements like turmeric/curcumin or glucosamine have mixed evidence—discuss with your clinician, especially if you take blood thinners

(If you want, I can turn this section into a one-page “knee pain toolkit” handout for your 60+ audience.)

Which benefits the patient most—and lasts the longest?

• If the goal is the longest-lasting structural solution, total knee replacement wins: many implants last decades and it can dramatically improve pain/function when OA is advanced. The Lancet
• If the goal is lower risk, faster recovery, and a way to delay surgery (especially in mild-to-moderate OA or higher surgical risk), GAE may be worth discussing—recognizing that not everyone responds and long-term durability is still being studied. PMC+2Jvir+2

A practical way to frame it for adults over 60:

• Mild–moderate OA, not ready for surgery → consider PT + injections; if still limited, ask about GAE.
• Severe OA with major functional loss → TKR is often the most definitive option (if medically fit).
• Complex medical issues → minimally invasive options (including GAE) may be considered in specialized centers with careful counseling. RSNA+1

Stay informed. Join us at newsletter@erinsagelessessentials.com for any updates and trending information that impact our elder and senior communities.